Medpace Holdings Inc
NASDAQ:MEDP

Watchlist Manager
Medpace Holdings Inc Logo
Medpace Holdings Inc
NASDAQ:MEDP
Watchlist
Price: 305.66 USD 3.12% Market Closed
Market Cap: 8.8B USD
Have any thoughts about
Medpace Holdings Inc?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Medpace Holdings Inc

Revenue
2.2B USD
Cost of Revenue
-1.5B USD
Gross Profit
679.5m USD
Operating Expenses
-223.2m USD
Operating Income
456.3m USD
Other Expenses
-39.9m USD
Net Income
416.4m USD

Margins Comparison
Medpace Holdings Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Medpace Holdings Inc
NASDAQ:MEDP
9.1B USD
32%
21%
19%
US
PerkinElmer Inc
LSE:0KHE
1T USD
56%
15%
10%
US
Thermo Fisher Scientific Inc
NYSE:TMO
155.6B USD
41%
18%
15%
US
Danaher Corp
NYSE:DHR
140.3B USD
60%
22%
16%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
50%
29%
24%
CH
Lonza Group AG
SIX:LONN
40.1B CHF
37%
18%
10%
US
Agilent Technologies Inc
NYSE:A
32.5B USD
54%
24%
19%
CN
WuXi AppTec Co Ltd
SSE:603259
177.2B CNY
42%
27%
27%
US
IQVIA Holdings Inc
NYSE:IQV
24.9B USD
35%
15%
9%
US
Mettler-Toledo International Inc
NYSE:MTD
24.1B USD
60%
29%
22%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.5B EUR
44%
14%
7%
No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Medpace Holdings Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Medpace Holdings Inc
NASDAQ:MEDP
9.1B USD
66%
23%
57%
29%
US
PerkinElmer Inc
LSE:0KHE
1T USD
4%
2%
3%
3%
US
Thermo Fisher Scientific Inc
NYSE:TMO
155.6B USD
14%
7%
9%
8%
US
Danaher Corp
NYSE:DHR
140.3B USD
7%
5%
7%
6%
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW
11%
7%
11%
7%
CH
Lonza Group AG
SIX:LONN
40.1B CHF
7%
4%
8%
6%
US
Agilent Technologies Inc
NYSE:A
32.5B USD
21%
11%
16%
14%
CN
WuXi AppTec Co Ltd
SSE:603259
177.2B CNY
20%
14%
17%
16%
US
IQVIA Holdings Inc
NYSE:IQV
24.9B USD
22%
5%
11%
8%
US
Mettler-Toledo International Inc
NYSE:MTD
24.1B USD
-499%
26%
52%
31%
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.5B EUR
5%
2%
5%
4%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less